For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, ReShape Lifesciences Inc (NASDAQ: RSLS) closed at $5.66 up 1.07% from its previous closing price of $5.60. In other words, the price has increased by $1.07 from its previous closing price. On the day, 1.32 million shares were traded. RSLS stock price reached its highest trading level at $6.0 during the session, while it also had its lowest trading level at $4.89.
Ratios:
For a deeper understanding of ReShape Lifesciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.90. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 31 ’24 when STANKOVICH THOMAS sold 48 shares for $0.25 per share. The transaction valued at 12 led to the insider holds 22,777 shares of the business.
STANKOVICH THOMAS sold 42 shares of RSLS for $10 on Dec 31 ’23. The Chief Financial Officer now owns 22,868 shares after completing the transaction at $0.25 per share. On Nov 30 ’23, another insider, STANKOVICH THOMAS, who serves as the Chief Financial Officer of the company, sold 39 shares for $0.23 each. As a result, the insider received 9 and left with 22,910 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RSLS now has a Market Capitalization of 2867780 and an Enterprise Value of 2030786. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.37 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 0.252 whereas that against EBITDA is -0.221.
Stock Price History:
Over the past 52 weeks, RSLS has reached a high of $34.22, while it has fallen to a 52-week low of $4.60. The 50-Day Moving Average of the stock is -13.21%, while the 200-Day Moving Average is calculated to be -41.82%.
Shares Statistics:
For the past three months, RSLS has traded an average of 195.23K shares per day and 115190 over the past ten days. A total of 0.51M shares are outstanding, with a floating share count of 0.47M. Insiders hold about 7.44% of the company’s shares, while institutions hold 3.45% stake in the company. Shares short for RSLS as of 1728950400 were 14680 with a Short Ratio of 0.08, compared to 1726185600 on 9946. Therefore, it implies a Short% of Shares Outstanding of 14680 and a Short% of Float of 3.17.
